Taro Pharmaceutical
TARO
#5070
Rank
S$2.08 B
Marketcap
S$55.51
Share price
0.00%
Change (1 day)
4.20%
Change (1 year)

Taro Pharmaceutical (TARO) - Cash on Hand

Cash on Hand as of December 2023 : S$1.16 Billion

According to Taro Pharmaceutical's latest financial reports the company has S$1.16 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Taro Pharmaceutical - Cash on Hand chart (from 1996 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2023-03-31S$1.13 B1.73%
2022-03-31S$1.11 B-19.27%
2021-03-31S$1.37 B-12.65%
2020-03-31S$1.57 B10.93%
2019-03-31S$1.42 B-23.82%
2018-03-31S$1.86 B-3.68%
2017-03-31S$1.93 B16.91%
2016-03-31S$1.65 B31.12%
2015-03-31S$1.26 B58.82%
2014-03-31S$0.79 B15.9%
2013-03-31S$0.68 B
2011-12-31S$0.31 B174.68%
2010-12-31S$0.11 B-28.68%
2009-12-31S$0.16 B42.32%
2008-12-31S$0.11 B73.37%
2007-12-31S$65.02 M160.89%
2006-12-31S$24.92 M-79.48%
2005-12-31S$0.12 B-24.5%
2004-12-31S$0.16 B-40.48%
2003-12-31S$0.27 B19.19%
2002-12-31S$0.22 B-20%
2001-12-31S$0.28 B2157.82%
2000-12-31S$12.55 M151.13%
1999-12-31S$4.99 M175.31%
1998-12-31S$1.81 M34.65%
1997-12-31S$1.34 M60.63%
1996-12-31S$0.83 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
S$19.35 B 1,560.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$23.52 B 1,918.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$23.97 B 1,957.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.84 B 144.18%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
S$5.74 B 392.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
S$12.59 B 981.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland